Dr Reddy's gearing up to get substantial slice of Revlimid generic opportunity in USRevlimid is a top-selling cancer drug from Bristol Myers Squibb. Its generic form, called lenalidomide, is seen as Dr Reddy's most anticipa...
09 Aug, 2022, 07.40 PM IST
Submitted proposal to DCGI to test Sputnik Light as Covid booster dose: Dr Reddy's"As regards to Sputnik, we are now ready with capacities in India. We are working actively with the Government of India for registering Spu...
06 Feb, 2022, 12.19 PM IST
Dr Reddy's lines up Rs 1,000 crore capex for current fiscal yearThe Hyderabad based firm invested about Rs 1,000 crore in the 2020-21 fiscal year.
24 May, 2021, 01.04 PM IST
Dr Reddy's in talks with RDIF on Sputnik V for other countriesDr Reddy's which had received over two lakh vaccines from RDIF, recently soft-launched Sputnik V and tied up with Apollo Hospitals for pilo...
19 May, 2021, 01.29 PM IST
Aurobindo Pharma may buy Portugal's Generis, deal likely to be valued at $200 millionAurobindo's latest bid comes on the heels of last month’s shot at Israeli drug maker Teva's UK product portfolio, where it was outbid by ri...
03 Nov, 2016, 01.22 AM IST
Teva may move court against Dr Reddy's for patent infringementThe Israeli drug maker already is involved in various legal battles with other drug firms over the patent litigations of Copaxone.
11 Aug, 2014, 03.50 PM IST
Teva Pharmaceutical recalls 38,858 bottles of drugs made by Emcure Pharmaceuticals in US marketThe company is also recalling 7,694 bottles of anti- inflammatory drug indomethacin 25 mg, produced by Emcure Pharma, for non-adherence to ...
22 May, 2014, 05.41 PM IST
US Patents rejects Teva's plea on Copaxone; Natco shares upHyderabad-based Natco markets Copaxone (Glatiramer Acetate) -- used in the treatment of relapsing-remitting multiple sclerosis -- in the US...
05 Apr, 2014, 04.49 AM IST
Claris Lifesciences gets USFDA drug approvalClaris Lifesciences Ltd, a parenteral drug company has received drug approval from US drug authorities for hypertension and angina treatmen...
01 May, 2013, 04.22 PM IST
- Pharmaceutical companies should consider mergers: Dilip Shanghvi
Pharmaceutical companies, who are battling growing competition from each other and resurgent multinationals, may have to shake hands.
11 Jan, 2012, 02.31 AM IST
- Sun Pharma buys controlling stake in Taro, shares up
Sun Pharmaceuticals today said it has acquired a controlling stake in Israeli pharma major Taro Pharmaceuticals.
22 Sep, 2010, 11.29 AM IST
- Taro accuses Sun of waging proxy war
Israeli drug maker Taro Pharma has alleged that Sun Pharma is attempting to seize its control by waging a proxy war.
09 Dec, 2009, 08.00 PM IST
- Sun Pharma extends open offer to April 17, 2009
Sun Pharmaceutical Industries has extended the open offer for acquiring shares of Israeli drug maker Taro Pharmaceutical which was schedule...
03 Apr, 2009, 08.00 PM IST
- Sun Pharma extends open offer to April 3, 2009
Sun Pharmaceutical Industries has extended the open offer, which was to expire today, for acquiring shares of Israeli drug maker Taro Pharm...
21 Mar, 2009, 09.06 PM IST
- Sun Pharma extends Taro open offer till October 3
Drug maker Sun Pharmaceuticals open offer for purchase of all outstanding shares of Taro has been extended to October 3 with a possibility ...
04 Sep, 2008, 02.30 PM IST
- Indian drug makers eye US firm Par Pharma
India's top drug makers are in the race to acquire US-based generic drug maker, Par Pharmaceutical Co Inc, two Indian newspapers reported o...
18 Sep, 2007, 11.30 AM IST
- Sun may hike offer for Taro stake
Sun Pharmaceutical Industries, which has been struggling over the last few months to gain control over Israel’s Taro Pharmaceutical Industr...
13 Sep, 2007, 05.15 AM IST